Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, Hirohashi S, Vissing H, Shimizu M, Oshimura M
National Cancer Center Research Institute, Tokyo, Japan.
Oncogene. 1993 Jul;8(7):1825-32.
Deletion mapping of chromosome 3p was performed on 47 cases of human uterine cervical cancer using 24 polymorphic DNA markers including five inter-Alu DNA markers and two NotI-boundary cosmid markers obtained in our laboratory. The most likely order of these 24 polymorphic DNA markers was determined as being cen-[D3S4, H8]-D3S693-D3S659-D3S30-D3S687-[D3S2, UR9, UR47]-J36-J17-GNAI2B-D3F15S2-D3S643- D3S32-D3S23-D3S686-H35-UR189-D3S685-D3S 11 - D3S12-THRB-D3S22-pter, based on the data from radiation hybrid mapping genetic linkage analysis and in situ hybridization. Loss of heterozygosity (LOH) at one or more loci on chromosome 3p was detected in 21 of 47 cases (45%). Four tumors showed partial or interstitial deletions, and the common region of LOH in these tumors was 3p13-p21.1 between the D3S30 marker and the D3S2 marker. Candidates for tumor-suppressor genes, APEH, D8, GNA12B, ZNF35, RARB, THRB and RAFI, were all mapped outside of the common region in uterine cervical cancer. However, this region is commonly deleted in carcinoma of the lung, breast and kidney, and encompasses the breakpoint of the (3;8) translocation in hereditary renal cell carcinoma. This result indicates the presence of a novel tumor-suppressor gene in the region of 3p13-p21.1, which is involved in the development of several human cancers.
使用包括5个Alu间DNA标记和2个在我们实验室获得的NotI边界黏粒标记在内的24个多态性DNA标记,对47例人子宫颈癌进行了3号染色体短臂(3p)的缺失定位。根据辐射杂种定位、遗传连锁分析和原位杂交的数据,确定这24个多态性DNA标记的最可能顺序为:着丝粒-[D3S4, H8]-D3S693-D3S659-D3S30-D3S687-[D3S2, UR9, UR47]-J36-J17-GNAI2B-D3F15S2-D3S643-D3S32-D3S23-D3S686-H35-UR1,89-D3S685-D3S11-D3S12-THRB-D3S22-端粒。在47例中的21例(4)5%)检测到3p上一个或多个位点的杂合性缺失(LOH)。4个肿瘤显示部分或间质缺失,这些肿瘤中LOH的共同区域位于D3S30标记和D3S2标记之间的3p13-p21.1。肿瘤抑制基因候选物APEH、D8、GNA12B、ZNF35、RARB、THRB和RAFI均定位于子宫颈癌共同区域之外。然而,该区域在肺癌、乳腺癌和肾癌中常被缺失,并且包含遗传性肾细胞癌中(3;8)易位的断点。这一结果表明在3p13-p21.1区域存在一个新的肿瘤抑制基因,其参与多种人类癌症的发生发展。